QQQ   430.57 (-0.11%)
AAPL   169.36 (-1.93%)
MSFT   416.14 (+0.60%)
META   500.93 (+0.14%)
GOOGL   154.89 (+0.02%)
AMZN   183.65 (+0.02%)
TSLA   156.52 (-3.07%)
NVDA   873.98 (+1.62%)
AMD   163.23 (+1.82%)
NIO   3.82 (-1.80%)
BABA   69.92 (-0.99%)
T   16.00 (-1.48%)
F   12.14 (-0.74%)
MU   121.04 (-0.27%)
GE   155.38 (+1.09%)
CGC   6.84 (-2.01%)
DIS   113.72 (+0.68%)
AMC   2.88 (+16.60%)
PFE   25.76 (-0.58%)
PYPL   63.66 (+0.24%)
XOM   118.19 (-1.24%)
QQQ   430.57 (-0.11%)
AAPL   169.36 (-1.93%)
MSFT   416.14 (+0.60%)
META   500.93 (+0.14%)
GOOGL   154.89 (+0.02%)
AMZN   183.65 (+0.02%)
TSLA   156.52 (-3.07%)
NVDA   873.98 (+1.62%)
AMD   163.23 (+1.82%)
NIO   3.82 (-1.80%)
BABA   69.92 (-0.99%)
T   16.00 (-1.48%)
F   12.14 (-0.74%)
MU   121.04 (-0.27%)
GE   155.38 (+1.09%)
CGC   6.84 (-2.01%)
DIS   113.72 (+0.68%)
AMC   2.88 (+16.60%)
PFE   25.76 (-0.58%)
PYPL   63.66 (+0.24%)
XOM   118.19 (-1.24%)
QQQ   430.57 (-0.11%)
AAPL   169.36 (-1.93%)
MSFT   416.14 (+0.60%)
META   500.93 (+0.14%)
GOOGL   154.89 (+0.02%)
AMZN   183.65 (+0.02%)
TSLA   156.52 (-3.07%)
NVDA   873.98 (+1.62%)
AMD   163.23 (+1.82%)
NIO   3.82 (-1.80%)
BABA   69.92 (-0.99%)
T   16.00 (-1.48%)
F   12.14 (-0.74%)
MU   121.04 (-0.27%)
GE   155.38 (+1.09%)
CGC   6.84 (-2.01%)
DIS   113.72 (+0.68%)
AMC   2.88 (+16.60%)
PFE   25.76 (-0.58%)
PYPL   63.66 (+0.24%)
XOM   118.19 (-1.24%)
QQQ   430.57 (-0.11%)
AAPL   169.36 (-1.93%)
MSFT   416.14 (+0.60%)
META   500.93 (+0.14%)
GOOGL   154.89 (+0.02%)
AMZN   183.65 (+0.02%)
TSLA   156.52 (-3.07%)
NVDA   873.98 (+1.62%)
AMD   163.23 (+1.82%)
NIO   3.82 (-1.80%)
BABA   69.92 (-0.99%)
T   16.00 (-1.48%)
F   12.14 (-0.74%)
MU   121.04 (-0.27%)
GE   155.38 (+1.09%)
CGC   6.84 (-2.01%)
DIS   113.72 (+0.68%)
AMC   2.88 (+16.60%)
PFE   25.76 (-0.58%)
PYPL   63.66 (+0.24%)
XOM   118.19 (-1.24%)

IDEXX Laboratories (IDXX) SEC Filings & 10K Form

$493.59
+2.30 (+0.47%)
(As of 01:51 PM ET)

Recent IDEXX Laboratories SEC Filings

DateFilerForm TypeView
03/06/2024
4:56 PM
IDEXX Laboratories (Subject)
POLEWACZYK JAMES F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
4:36 PM
IDEXX Laboratories (Subject)
Vandebroek Sophie V. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/22/2024
3:17 PM
IDEXX Laboratories (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/16/2024
4:54 PM
Erickson Michael G (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:55 PM
FENNELL GEORGE (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:55 PM
Hunt Nimrata (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:56 PM
IDEXX Laboratories (Issuer)
Johnson Michael Perkins (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:56 PM
IDEXX Laboratories (Issuer)
Lane Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:56 PM
IDEXX Laboratories (Issuer)
MAZELSKY JONATHAN JAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:57 PM
IDEXX Laboratories (Issuer)
MCKEON BRIAN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:57 PM
IDEXX Laboratories (Issuer)
POLEWACZYK JAMES F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:58 PM
IDEXX Laboratories (Issuer)
Schreck Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:58 PM
IDEXX Laboratories (Issuer)
Smith Martin Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
4:58 PM
IDEXX Laboratories (Issuer)
Underberg Sharon E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
4:01 PM
IDEXX Laboratories (Issuer)
MCKEON BRIAN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
4:02 PM
AYERS JONATHAN W (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
4:03 PM
FENNELL GEORGE (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
4:26 PM
FENNELL GEORGE (Reporting)
IDEXX Laboratories (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2024
6:01 PM
IDEXX Laboratories (Subject)
MAZELSKY JONATHAN JAY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2024
5:17 PM
IDEXX Laboratories (Subject)
MCKEON BRIAN P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2024
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
4:00 PM
IDEXX Laboratories (Issuer)
JUNIUS DANIEL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
IDEXX Laboratories (Subject)
Form SC 13G/A
01/05/2024
4:01 PM
FENNELL GEORGE (Reporting)
IDEXX Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/05/2024
4:02 PM
IDEXX Laboratories (Issuer)
Schreck Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/08/2023
4:00 PM
IDEXX Laboratories (Issuer)
POLEWACZYK JAMES F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
4:01 PM
IDEXX Laboratories (Subject)
POLEWACZYK JAMES F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
4:01 PM
IDEXX Laboratories (Issuer)
MAZELSKY JONATHAN JAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
4:00 PM
AYERS JONATHAN W (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
5:50 PM
AYERS JONATHAN W (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
4:09 PM
IDEXX Laboratories (Issuer)
Lane Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2023
5:06 PM
IDEXX Laboratories (Issuer)
JUNIUS DANIEL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2023
3:20 PM
IDEXX Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2023
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2023
4:00 PM
Britt Irene Chang (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:01 PM
IDEXX Laboratories (Issuer)
Smith Martin Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2023
5:02 PM
IDEXX Laboratories (Subject)
MAZELSKY JONATHAN JAY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/31/2023
4:17 PM
IDEXX Laboratories (Issuer)
POLEWACZYK JAMES F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2023
4:25 PM
IDEXX Laboratories (Subject)
POLEWACZYK JAMES F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/17/2023
6:37 PM
AYERS JONATHAN W (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
4:59 PM
IDEXX Laboratories (Issuer)
MAZELSKY JONATHAN JAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Can't believe it's happening again (Ad)

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.
08/08/2023
4:59 PM
IDEXX Laboratories (Issuer)
MCKEON BRIAN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
4:57 PM
IDEXX Laboratories (Subject)
Lane Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2023
4:19 PM
IDEXX Laboratories (Issuer)
JUNIUS DANIEL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2023
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2023
4:00 PM
Britt Irene Chang (Reporting)
IDEXX Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/12/2023
6:01 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2023
6:55 PM
AYERS JONATHAN W (Reporting)
IDEXX Laboratories (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2023
5:43 PM
IDEXX Laboratories (Subject)
Turner Kathy V (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2023
4:31 PM
AYERS JONATHAN W (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
4:31 PM
COLLINS Asha (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
4:31 PM
ESSIG STUART (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
4:32 PM
IDEXX Laboratories (Issuer)
Kingsley Lawrence D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
4:32 PM
IDEXX Laboratories (Issuer)
SZOSTAK M ANNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
4:32 PM
IDEXX Laboratories (Issuer)
Vandebroek Sophie V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2023
4:01 PM
AYERS JONATHAN W (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2023
6:20 PM
IDEXX Laboratories (Subject)
Turner Kathy V (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2023
5:00 PM
IDEXX Laboratories (Issuer)
MAZELSKY JONATHAN JAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2023
5:01 PM
IDEXX Laboratories (Issuer)
Vandebroek Sophie V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2023
4:38 PM
IDEXX Laboratories (Subject)
Lane Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2023
3:53 PM
IDEXX Laboratories (Subject)
SZOSTAK M ANNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/04/2023
4:57 PM
IDEXX Laboratories (Subject)
Vandebroek Sophie V. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2023
5:01 PM
IDEXX Laboratories (Issuer)
JUNIUS DANIEL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
5:34 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:IDXX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners